Faecal Analyses in Spondyloarthritis Therapy

Recruiting now

Conditions studied: Spondyloarthropathies, Ankylosing Spondylitis

In brief

This study evaluates the intestinal microbiome and disease activity in patients with spondyloarthropathies receiving immunosuppressive therapy. Patients will be analysed at two time points in reference to two predefined primary endpoints: * Changes in intestinal microbiome * Response to therapy The investigators want to evaluate if successful treatment of spondylarthropathy coincide with specific changes in the gut flora.

Key facts

Study ID

NCT03839862

Run by

Region Skane

People needed

50

Starts

2019-01-01

Expected to finish

2026-12-31

Last updated by the study team

2024-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fulfilling the Assessment of SpondyloArthritis International Society classification criteria for spondyloarthropathy.
• About to commence treatment with TNF-inhibition

You may not qualify if…

• Failure to understand protocol
• A history of alcohol abuse
• Any history of diverticulitis
• A history of failure to comply with prescribed medication
• Ongoing biological therapy

Where it is running

• Reumatologi SUS Lund, Region Skåne — Lund, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.